Gsk Operating Expenses Growth & History (GSK)
Gsk's operating expenses was £15.72B for fiscal 2025.
View full Gsk company overviewGsk annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £15.72B | −£2.59B | −14.14% |
| 2024 | 2024-12-31 | £18.31B | £3.29B | +21.90% |
| 2023 | 2023-12-31 | £15.02B | £1.68B | +12.60% |
| 2022 | 2022-12-31 | £13.34B | £1.16B | +9.54% |
| 2021 | 2021-12-31 | £12.18B | £1.73B | +16.56% |
| 2020 | 2020-12-31 | £10.45B | −£4.48B | −30.03% |
| 2019 | 2019-12-31 | £14.93B | −£167.0M | −1.11% |
| 2018 | 2018-12-31 | £15.10B | −£660.0M | −4.19% |
| 2017 | 2017-12-31 | £15.76B | −£244.0M | −1.52% |
| 2016 | 2016-12-31 | £16.00B | £11.25B | +237.01% |
| 2015 | 2015-12-31 | £4.75B | — | — |
Gsk quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | £5.66B | £1.86B | +49.08% |
| Q1 2026 | 2026-03-31 | £3.46B | — | — |
| Q4 2025 | 2025-12-31 | £4.46B | — | — |
| Q3 2025 | 2025-09-30 | £3.70B | — | — |
| Q2 2025 | 2025-06-30 | £3.80B | — | — |
Gsk operating expenses trends
Over the last five fiscal years, Gsk's operating expenses increased from £10.45B to £15.72B, a change of £5.27B. The latest reported quarter, Q2 2026, shows £5.66B.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gsk source filings ↗